David J Taber1,2, Kelly J Hunt3, Mulugeta Gebregziabher3, Titte Srinivas4, Kenneth D Chavin5, Prabhakar K Baliga5, Leonard E Egede6. 1. Divisions of Transplant Surgery and taberd@musc.edu. 2. Department of Pharmacy Services and. 3. Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina; and. 4. Transplant Nephrology and. 5. Divisions of Transplant Surgery and. 6. Department of Medicine, Veteran Affairs Health Services Research and Development, Health Equity and Rural Outreach Innovation Center, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina.
Abstract
BACKGROUND AND OBJECTIVES: There is continued debate whether early steroid withdrawal is safe to use in high-immunologic risk patients, such as blacks. The goal of this study was to use comparative effectiveness methodology to elucidate the safety of early steroid withdrawal in blacks with kidney transplants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our cohort study used United Network of Organ Sharing data including all adult black kidney transplant recipients from 2000 to 2009 followed through 2014. Propensity score matching was used to equalize baseline risk between continued steroid and early steroid withdrawal groups. Interaction terms were used to assess if the effect of early steroid withdrawal on outcomes varied by baseline and post-transplant factors. Of 26,582 eligible black patients with kidney transplants (5825 [21.9%] with early steroid withdrawal), 5565 patients with early steroid withdrawal were matched to 5565 blacks on continued steroid use. RESULTS: Black patients with early steroid withdrawal had similar risk of graft loss (hazard ratio, 0.98; 95% confidence interval, 0.92 to 1.04; P=0.42) and lower risk of death (hazard ratio, 0.91; 95% confidence interval, 0.84 to 0.99; P=0.02), primarily driven by a late mortality advantage (>4 years post-transplant). Delayed graft function, cytolytic induction, tacrolimus, and mycophenolate significantly modified the effect of early steroid withdrawal on outcomes (P<0.05). Acute rejection rates were slightly higher in the continued steroid group (13.0% versus 11.3%, respectively; P<0.01), but this was not associated with graft or patient survival. CONCLUSIONS: Overall, early steroid withdrawal in black kidney transplant recipients was not associated with graft loss but seemed to be associated with better long-term patient survival. Early steroid withdrawal in blacks not receiving cytolytic induction, tacrolimus, and mycophenolate or those with delayed graft function was associated with higher risk of graft loss and death.
BACKGROUND AND OBJECTIVES: There is continued debate whether early steroid withdrawal is safe to use in high-immunologic risk patients, such as blacks. The goal of this study was to use comparative effectiveness methodology to elucidate the safety of early steroid withdrawal in blacks with kidney transplants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our cohort study used United Network of Organ Sharing data including all adult black kidney transplant recipients from 2000 to 2009 followed through 2014. Propensity score matching was used to equalize baseline risk between continued steroid and early steroid withdrawal groups. Interaction terms were used to assess if the effect of early steroid withdrawal on outcomes varied by baseline and post-transplant factors. Of 26,582 eligible black patients with kidney transplants (5825 [21.9%] with early steroid withdrawal), 5565 patients with early steroid withdrawal were matched to 5565 blacks on continued steroid use. RESULTS: Black patients with early steroid withdrawal had similar risk of graft loss (hazard ratio, 0.98; 95% confidence interval, 0.92 to 1.04; P=0.42) and lower risk of death (hazard ratio, 0.91; 95% confidence interval, 0.84 to 0.99; P=0.02), primarily driven by a late mortality advantage (>4 years post-transplant). Delayed graft function, cytolytic induction, tacrolimus, and mycophenolate significantly modified the effect of early steroid withdrawal on outcomes (P<0.05). Acute rejection rates were slightly higher in the continued steroid group (13.0% versus 11.3%, respectively; P<0.01), but this was not associated with graft or patient survival. CONCLUSIONS: Overall, early steroid withdrawal in black kidney transplant recipients was not associated with graft loss but seemed to be associated with better long-term patient survival. Early steroid withdrawal in blacks not receiving cytolytic induction, tacrolimus, and mycophenolate or those with delayed graft function was associated with higher risk of graft loss and death.
Authors: D O McDaniel; W H Barber; C Nguyan; S W Rhodes; W L May; L S McDaniel; P J S Vig; L L Jemeson; D E Butkus Journal: Transpl Immunol Date: 2003 Jan-Mar Impact factor: 1.708
Authors: A J Matas; J M Smith; M A Skeans; B Thompson; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; G Boyle; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: Donald E Hricik; Joshua J Augustine; Thomas C Knauss; Kenneth A Bodziak; Mark Aeder; Christopher Siegel; James A Schulak Journal: Transplantation Date: 2007-02-15 Impact factor: 4.939
Authors: David J Taber; Mulugeta G Gebregziabher; Titte R Srinivas; Kenneth D Chavin; Prabhakar K Baliga; Leonard E Egede Journal: Pharmacotherapy Date: 2015-05-23 Impact factor: 4.705
Authors: David J Taber; John W McGillicuddy; Charles F Bratton; Vinayak S Rohan; Satish Nadig; Derek Dubay; Prabhakar K Baliga Journal: Ann Surg Date: 2017-09 Impact factor: 12.969
Authors: William A Werbel; Sunjae Bae; Sile Yu; Fawaz Al Ammary; Dorry L Segev; Christine M Durand Journal: Am J Transplant Date: 2020-08-13 Impact factor: 8.086
Authors: David J Taber; Mulugeta Gebregziabher; Titte Srinivas; Leonard E Egede; Prabhakar K Baliga Journal: Ann Transplant Date: 2018-02-16 Impact factor: 1.530
Authors: Jun B Bang; Chang-Kwon Oh; Yu S Kim; Sung H Kim; Hee C Yu; Chan-Duck Kim; Man Ki Ju; Byung J So; Sang Ho Lee; Sang Y Han; Cheol W Jung; Joong K Kim; Hyung J Ahn; Su H Lee; Ja Y Jeon Journal: Immun Inflamm Dis Date: 2021-12-15